| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c577ec7b0363a5d21ee652a580ea98f1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_951628f74f0e41cdf55aeee980cc4e2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ae83bfaec51efbe8ee36777b0bb877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b4ce50bf5515191178dc4abe25474b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a95b74bfc8b76d4282f22d3d4ce508f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2e8f5acfc571f062b1356919c1fd1be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4f79ad11beb80339f4f48561d99245d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826a1b62cde7c898aad07f85038f8d80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b4bd8f1c4a37377583c922e8e6beaa |
| publicationDate |
2011-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8030014-B2 |
| titleOfInvention |
Detecting agent and therapeutic agent for highly malignant breast cancer |
| abstract |
A detection agent for high malignancy breast cancer includes an antibody against collagen XIV, or a variant or derivative or fragment of the antibody. A therapeutic agent for high malignancy breast cancer includes a conjugate of an anticancer drug and an antibody against that protein, or a variant or derivative or fragment thereof. Accordingly, it is possible to easily and accurately detect and diagnose high malignancy breast cancer. |
| priorityDate |
2005-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |